(Q44860113)

6 December 2017

title

Prognostic markers in node-negative breast cancer: a prospective study (English)

1 reference

6 December 2017

Kute TE

1

1 reference

6 December 2017

Russell GB

2

1 reference

6 December 2017

Zbieranski N

3

1 reference

6 December 2017

Long R

4

1 reference

6 December 2017

Johnston S

5

1 reference

6 December 2017

Williams H

6

1 reference

6 December 2017

Stackhouse C

7

1 reference

6 December 2017

Wilkins L

8

1 reference

6 December 2017

Evans I

9

1 reference

6 December 2017

Berry P

10

1 reference

6 December 2017

Rimmer K

11

1 reference

6 December 2017

Tucker E

12

1 reference

6 December 2017

publication date

1 May 2004

1 reference

Cytometry Part B: Clinical Cytometry

6 December 2017

published in

1 reference

6 December 2017

volume

59

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

24-31

1 reference

DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

S-phase fraction and breast cancer--a decade of experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20003

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20003

1 reference

6 December 2017

1 reference